Michael Barbella, Managing Editor04.27.24
Cybervisitors dreaming of a new sleep solution drove the preponderance of MPO website traffic this past week.
News of AIOMEGA's FDA-cleared obstructive sleep apnea treatment solution, AIO BREATHE, outpaced all other stories in pageviews. AIO BREATHE is a new mandibular repositioning device that increases the patient’s airway during sleep, improving the ability to exchange air and thereby reducing the tendency to snore. AIO Breathe features right and left protrusive flanges that engage with corresponding right and left vertical flanges. This engagement repositions the jaw to reflect the dentist’s prescribed anterior mandibular advancement and is maintained while mouth is open or closed. Additionally, mandibular plateaus guide the mandible downward, thus opening the anterior airway. AIO Breathe is intended to reduce or alleviate snoring and mild to moderate obstructive sleep apnea while sleeping in adult patients.
Though their open-rate totals paled in comparison to AIOMEGA's, both Medtronic and Teleflex landed in the top five hit list. Medtronic enticed site loyalists by releasing a new aortic valve, while Teleflex followed suit by marking the opening of an expanded manufacturing plant.
Medtronic's next-generation surgical aortic tissue valve, Avalus Ultra, features a low valve profile, as well as a PEEK baseframe, industry-leading Effective Orifice Area (EOA), and radiopaque coil. It earned FDA approval in January and is, at present, only commercially available in the United States.
Teleflex's 8,200-square-foot expansion to its Jaffrey, N.H., facility has several extrusion lines for manufacturing a greater number of polytetrafluoroethylene tubing and fluorinated ethylene propylene heat shrink products. The Wayne, Pa.-based firm bolstered its extrusion capabilities to meeting rising customer demand for precision extrusion and access devices used in critical medical applications.
Other items of interest this past week included two magazine features on the state of medical device outsourcing and the in-vitro diagnostics market.
News of AIOMEGA's FDA-cleared obstructive sleep apnea treatment solution, AIO BREATHE, outpaced all other stories in pageviews. AIO BREATHE is a new mandibular repositioning device that increases the patient’s airway during sleep, improving the ability to exchange air and thereby reducing the tendency to snore. AIO Breathe features right and left protrusive flanges that engage with corresponding right and left vertical flanges. This engagement repositions the jaw to reflect the dentist’s prescribed anterior mandibular advancement and is maintained while mouth is open or closed. Additionally, mandibular plateaus guide the mandible downward, thus opening the anterior airway. AIO Breathe is intended to reduce or alleviate snoring and mild to moderate obstructive sleep apnea while sleeping in adult patients.
Though their open-rate totals paled in comparison to AIOMEGA's, both Medtronic and Teleflex landed in the top five hit list. Medtronic enticed site loyalists by releasing a new aortic valve, while Teleflex followed suit by marking the opening of an expanded manufacturing plant.
Medtronic's next-generation surgical aortic tissue valve, Avalus Ultra, features a low valve profile, as well as a PEEK baseframe, industry-leading Effective Orifice Area (EOA), and radiopaque coil. It earned FDA approval in January and is, at present, only commercially available in the United States.
Teleflex's 8,200-square-foot expansion to its Jaffrey, N.H., facility has several extrusion lines for manufacturing a greater number of polytetrafluoroethylene tubing and fluorinated ethylene propylene heat shrink products. The Wayne, Pa.-based firm bolstered its extrusion capabilities to meeting rising customer demand for precision extrusion and access devices used in critical medical applications.
Other items of interest this past week included two magazine features on the state of medical device outsourcing and the in-vitro diagnostics market.